These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10349942)

  • 21. [Hepatitis B virus markers and evaluation of prevention in hospital personnel].
    Fernández Sánchez S; Muñoz Domínguez F; Camarra Romero A; Fernández Diosdado MS
    Rev Sanid Hig Publica (Madr); 1985; 59(9-10):1125-36. PubMed ID: 3835690
    [No Abstract]   [Full Text] [Related]  

  • 22. [Humoral response in health service personnel after administration of hepatitis B vaccine Gen-H-B-Vax].
    Juszczyk J; Rokossowski H; Krajewska M; Piatek A
    Przegl Epidemiol; 1991; 45(1-2):11-6. PubMed ID: 1839075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How protective is the immunization against viral hepatitis B prospectively? Seroprevalence study on viral hepatitis B infection].
    Bocşan IS; Gocan G; Ursu L; Brumboiu MI; Soşa I; Simionca L; Sava A; Olaru O; Păştina I
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):124-30. PubMed ID: 16607840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responsiveness to intradermal recombinant hepatitis B vaccine.
    CDR (Lond Engl Wkly); 1991 Oct; 1(43):198. PubMed ID: 1669886
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis B virus reactivation in a large haemodialysis unit: virological and infection control issues.
    Bhattacharya S; Ijaz S; Ratnaraja N; Smith S; Osman H; Boxall E
    J Clin Virol; 2009 Sep; 46(1):101-3. PubMed ID: 19560397
    [No Abstract]   [Full Text] [Related]  

  • 26. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis B is an occupational risk for health personnel. Preventive vaccination is recommended].
    Struve J; Aronsson B; Forsgren M; Frenning B; von Sydow M; Weiland O
    Lakartidningen; 1996 Mar; 93(10):884-8. PubMed ID: 8656790
    [No Abstract]   [Full Text] [Related]  

  • 28. [Attitude of high-risk personnel to a hepatitis B vaccination campaign in a general hospital].
    San Miguel G; Ortiz de Diego R; Cabero MJ; Fernández Felgueroso E; Carrasco JL; Lardinois R; Pons Romero F
    Med Clin (Barc); 1988 Mar; 90(9):369-73. PubMed ID: 2969068
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers.
    Shim J; Kim KY; Kim BH; Chun H; Lee MS; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Vaccine; 2011 Feb; 29(8):1721-6. PubMed ID: 21147128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B vaccine. Key to the era of preventive control.
    Gregory DH
    Postgrad Med; 1984 Jan; 75(1):199-204, 209-11. PubMed ID: 6229723
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preliminary evaluation of the effect of anti-HBs immunoglobulin used in medical personnel at high risk of infection with the hepatitis B virus].
    Kacperska E; Seyfried H; Poszwiński P; Komandowski R; Mordarski S
    Acta Haematol Pol; 1985; 16(1-2):21-6. PubMed ID: 3832739
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
    Campos Nizama J
    Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
    Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
    J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control measures against hepatitis B infection.
    Frösner GG; Franco E
    Ann Ist Super Sanita; 1987; 24(2):267-75. PubMed ID: 2969204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.